Mupirocin - Epistaxis

You are here : Home > Formulary Search > Mupirocin - Epistaxis

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Green (see narrative)

Formulations :

Nasal ointment

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Associated Icons :

BNF SPC

Restrictions / Comments :

Important

2% nasal ointment. Off-label use - 2nd line as per CKS epistaxis guidance. Consider Naseptin unless unsuitable.

Documentation

No records returned.

PAD Profile

ChemicalSubstance :

Mupirocin

Indication :

Epistaxis

Group Name :

Keywords :

nosebleed

Brand Names Include :

Bactroban

Important Information :

Latest Additions Date From :

Latest Additions Date To :

Guidelines :

Supporting Documents :

Other Indications

Below are listed other indications that Mupirocin is used to treat.

Nasal staphylococci eradication

Other Drugs

Below are listed other drugs that are used to treat Epistaxis.

Committee Recommendations (1)

05 Feb 25 - Surrey Heartlands Integrated Care System Area Prescribing Committee (APC)

The Surrey Heartlands Area Prescribing Committee agreed the traffic light status of this drug and indication as part of the Joint Formulary review.